• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development of Positron Emission Tomography Radiotracers for the GABA Transporter 1.正电子发射断层扫描放射性示踪剂用于 GABA 转运蛋白 1 的开发。
ACS Chem Neurosci. 2018 Nov 21;9(11):2767-2773. doi: 10.1021/acschemneuro.8b00183. Epub 2018 May 24.
2
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance protein.18F 标记的氟拉西达作为 P-糖蛋白和乳腺癌耐药蛋白正电子发射断层扫描示踪剂的放射合成与体内评价。
Bioorg Med Chem. 2011 Apr 1;19(7):2190-8. doi: 10.1016/j.bmc.2011.02.039. Epub 2011 Feb 26.
3
Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.新型单羧酸转运蛋白配体 FACH 类似物的开发及一种潜在正电子发射断层扫描(PET)成像放射性示踪剂的生物学验证。
Molecules. 2020 May 14;25(10):2309. doi: 10.3390/molecules25102309.
4
Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.合成并评价了具有不对称双芳基残基连接乙烯基醚间隔基的 N-取代哌啶酸衍生物作为潜在的 GABA 摄取抑制剂。
Bioorg Med Chem. 2013 Jun 1;21(11):3363-78. doi: 10.1016/j.bmc.2013.02.056. Epub 2013 Apr 2.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Synthesis of a fluorine-18-labelled derivative of 6-nitroquipazine, as a radioligand for the in vivo serotonin transporter imaging with PET.6-硝基喹哌嗪的氟-18标记衍生物的合成,用作正电子发射断层扫描(PET)体内血清素转运体成像的放射性配体。
Bioorg Med Chem. 2002 Aug;10(8):2611-23. doi: 10.1016/s0968-0896(02)00098-6.
7
Inhibition of ABCB1 and ABCG2 at the Mouse Blood-Brain Barrier with Marketed Drugs To Improve Brain Delivery of the Model ABCB1/ABCG2 Substrate [C]erlotinib.用已上市药物抑制 ABCB1 和 ABCG2 可改善 ABCB1/ABCG2 底物[C]厄洛替尼在小鼠血脑屏障中的脑内传递。
Mol Pharm. 2019 Mar 4;16(3):1282-1293. doi: 10.1021/acs.molpharmaceut.8b01217. Epub 2019 Feb 11.
8
Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699.合成和正电子发射断层扫描放射性示踪剂的生物评价靶向脑 5-羟色胺 4 受体:[18F]MNI-698 和 [18F]MNI-699。
Bioorg Med Chem Lett. 2013 Dec 1;23(23):6243-7. doi: 10.1016/j.bmcl.2013.09.097. Epub 2013 Oct 9.
9
Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profile.发现一种人甜菜碱/γ-氨基丁酸转运蛋白 1(BGT-1)亚型选择性抑制剂,具有非竞争性药理学特征。
Biochem Pharmacol. 2013 Aug 15;86(4):521-8. doi: 10.1016/j.bcp.2013.06.007. Epub 2013 Jun 19.
10
Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.噻加宾、SK&F 89976 - A、CI - 966和NNC - 711对克隆的γ-氨基丁酸转运体GAT - 1具有选择性。
Eur J Pharmacol. 1994 Oct 14;269(2):219-24. doi: 10.1016/0922-4106(94)90089-2.

引用本文的文献

1
Imaging advances to detect non-motor prodromal markers of Parkinson's disease and explore therapeutic translation opportunities.成像技术的进展用于检测帕金森病的非运动前驱标志物并探索治疗转化机会。
NPJ Parkinsons Dis. 2025 Jun 18;11(1):174. doi: 10.1038/s41531-025-01004-0.
2
Synthesis, Radiosynthesis, in Vitro and in Vivo Evaluation of the GABA-Benzodiazepine Receptor Agonist [C]RO6899880.γ-氨基丁酸-苯二氮䓬受体激动剂[C]RO6899880的合成、放射性合成、体外和体内评价
ACS Med Chem Lett. 2025 Apr 2;16(5):844-850. doi: 10.1021/acsmedchemlett.5c00081. eCollection 2025 May 8.
3
Synthesis and Evaluation of Benzylic F-Labeled -Biphenylalkynyl Nipecotic Acid Derivatives for PET Imaging of GABA Transporter 1.用于γ-氨基丁酸转运体1正电子发射断层显像的苄基F标记的β-联苯乙炔基哌啶酸衍生物的合成与评价
ACS Chem Neurosci. 2025 Feb 19;16(4):711-722. doi: 10.1021/acschemneuro.4c00782. Epub 2025 Jan 29.
4
Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions.体内可视化γ-氨基丁酸转运体:已报道的放射性配体概述及未来方向
EJNMMI Res. 2023 May 12;13(1):42. doi: 10.1186/s13550-023-00992-5.
5
Classics in Neuroimaging: Development of Positron Emission Tomography Tracers for Imaging the GABAergic Pathway.神经影像学经典:正电子发射断层扫描示踪剂用于成像 GABA 能途径的发展。
ACS Chem Neurosci. 2020 Jul 15;11(14):2039-2044. doi: 10.1021/acschemneuro.0c00343. Epub 2020 Jun 24.

本文引用的文献

1
Synthesis and Evaluation of a New F-Labeled Radiotracer for Studying the GABA Receptor in the Mouse Brain.新型 F 标记放射性示踪剂的合成与评价及其在研究小鼠脑内 GABA 受体中的应用。
ACS Chem Neurosci. 2018 Jun 20;9(6):1453-1461. doi: 10.1021/acschemneuro.8b00038. Epub 2018 Mar 9.
2
Multiple Transmitter Receptors in Regions and Layers of the Human Cerebral Cortex.人类大脑皮层区域和层中的多种递质受体
Front Neuroanat. 2017 Sep 20;11:78. doi: 10.3389/fnana.2017.00078. eCollection 2017.
3
Small Molecule PET Tracers for Transporter Imaging.小分子 PET 示踪剂用于转运体成像。
Semin Nucl Med. 2017 Sep;47(5):536-552. doi: 10.1053/j.semnuclmed.2017.05.005. Epub 2017 Jul 5.
4
Preclinical PET Neuroimaging of [11C]Bexarotene.[11C]贝沙罗汀的临床前正电子发射断层扫描神经成像
Mol Imaging. 2016 Aug 23;15. doi: 10.1177/1536012116663054. Print 2016.
5
Structure Property Relationships of Carboxylic Acid Isosteres.羧酸生物电子等排体的结构-性质关系
J Med Chem. 2016 Apr 14;59(7):3183-203. doi: 10.1021/acs.jmedchem.5b01963. Epub 2016 Mar 30.
6
Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1.针对神经元γ-氨基丁酸转运体GAT1的肟类化合物库的生成与筛选。
ChemMedChem. 2015 Feb;10(2):396-410. doi: 10.1002/cmdc.201402376. Epub 2014 Nov 4.
7
A philosophy for CNS radiotracer design.一种中枢神经系统放射性示踪剂的设计理念。
Acc Chem Res. 2014 Oct 21;47(10):3127-34. doi: 10.1021/ar500233s. Epub 2014 Oct 1.
8
Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.[(11)C]N-甲基兰索拉唑作为用于tau神经原纤维缠结PET成像的放射性药物的评估。
ACS Med Chem Lett. 2012 Sep 25;3(11):936-41. doi: 10.1021/ml300216t. eCollection 2012 Nov 8.
9
PET radioligands targeting the brain GABAA /benzodiazepine receptor complex.靶向脑γ-氨基丁酸A型/苯二氮䓬受体复合物的正电子发射断层显像放射性配体
J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):196-206. doi: 10.1002/jlcr.3008.
10
Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.合成并评价了具有不对称双芳基残基连接乙烯基醚间隔基的 N-取代哌啶酸衍生物作为潜在的 GABA 摄取抑制剂。
Bioorg Med Chem. 2013 Jun 1;21(11):3363-78. doi: 10.1016/j.bmc.2013.02.056. Epub 2013 Apr 2.

正电子发射断层扫描放射性示踪剂用于 GABA 转运蛋白 1 的开发。

Development of Positron Emission Tomography Radiotracers for the GABA Transporter 1.

机构信息

Department of Radiology , University of Michigan Medical School , Ann Arbor , Michigan 48109 , United States.

Department of Medicinal Chemistry , University of Michigan , Ann Arbor , Michigan 48105 , United States.

出版信息

ACS Chem Neurosci. 2018 Nov 21;9(11):2767-2773. doi: 10.1021/acschemneuro.8b00183. Epub 2018 May 24.

DOI:10.1021/acschemneuro.8b00183
PMID:29763549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6249062/
Abstract

In vivo positron emission tomography (PET) imaging of the γ-aminobutyric acid (GABA) receptor complex has been accomplished using radiolabeled benzodiazepine derivatives, but development of specific presynaptic radioligands targeting the neuronal membrane GABA transporter type 1 (GAT-1) has been less successful. The availability of new structure-activity studies of GAT-1 inhibitors and the introduction of a GAT-1 inhibitor (tiagabine, Gabatril) into clinical use prompted us to reinvestigate the syntheses of PET ligands for this transporter. Initial synthesis and rodent PET studies of N-[C]methylnipecotic acid confirmed the low brain uptake of that small and polar molecule. The common design approach to improve blood-brain barrier permeability of GAT-1 inhibitors is the attachment of a large lipophilic substituent. We selected an unsymmetrical bis-aromatic residue attached to the ring nitrogen by a vinyl ether spacer from a series recently reported by Wanner and coworkers. Nucleophilic aromatic substitution of an aryl chloride precursor with [F]fluoride was used to prepare the desired candidate radiotracer ( R, E/ Z)-1-(2-((4-fluoro-2-(4-[F]fluorobenzoyl)styryl)oxy)ethyl)piperidine-3-carboxylic acid (( R, E/ Z)-[F]10). PET studies in rats showed no brain uptake, which was not altered by pretreatment of animals with the P-glycoprotein inhibitor cyclosporine A, indicating efflux by Pgp was not responsible. Subsequent PET imaging studies of ( R, E/ Z)-[F]10 in rhesus monkey brain showed very low brain uptake. Finally, to test if the free carboxylic acid group was the likely cause of poor brain uptake, PET studies were done using the ethyl ester derivative of ( R, E/ Z)-[F]10. Rapid and significant monkey brain uptake of the ester was observed, followed by a slow washout over 90 min. The blood-brain barrier permeability of the ester supports a hypothesis that the free acid function limits brain uptake of nipecotic acid-based GAT-1 radioligands, and future radiotracer efforts should investigate the use of carboxylic acid bioisosteres.

摘要

已使用放射性标记苯二氮䓬衍生物完成了γ-氨基丁酸(GABA)受体复合物的体内正电子发射断层扫描(PET)成像,但针对神经元膜 GABA 转运蛋白 1(GAT-1)的特异性突触前放射性配体的开发不太成功。新的 GAT-1 抑制剂结构活性研究的出现以及 GAT-1 抑制剂(噻加宾,Gabatril)在临床中的应用促使我们重新研究了该转运蛋白的 PET 配体的合成。对 N-[C]甲基哌可酸的初步合成和啮齿动物 PET 研究证实,该小分子和极性分子的脑摄取率较低。提高 GAT-1 抑制剂血脑屏障通透性的常用设计方法是连接大疏水性取代基。我们选择了一个不对称的双芳基残基,通过乙烯基醚间隔基连接到环氮上,该残基来自 Wanner 及其同事最近报道的一系列化合物。用[F]氟化物对芳基氯前体进行亲核芳香取代,制备所需的候选放射性示踪剂(R,E/Z)-1-(2-((4-氟-2-(4-[F]氟苯甲酰基)乙烯基)氧基)乙基)哌啶-3-羧酸((R,E/Z)-[F]10)。在大鼠中的 PET 研究显示没有脑摄取,用 P-糖蛋白抑制剂环孢素 A 预处理动物不会改变摄取情况,表明 Pgp 外排不是原因。随后在恒河猴脑中进行的(R,E/Z)-[F]10 的 PET 成像研究显示脑摄取非常低。最后,为了测试游离羧酸基团是否是脑摄取率低的可能原因,使用(R,E/Z)-[F]10 的乙酯衍生物进行了 PET 研究。观察到酯在猴子脑中的摄取迅速且显著,然后在 90 分钟内缓慢洗出。酯的血脑屏障通透性支持这样的假说,即游离酸的功能限制了基于哌可酸的 GAT-1 放射性配体的脑摄取,未来的示踪剂研究应探索使用羧酸的生物等排体。